Jewelry Television® (JTV) is showing support for the American Heart Association’s Go Red For Women® movement by launching “Love Your Heart,” a comprehensive, multimedia initiative aimed at raising awareness and educating viewers about the risks of heart disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60204-jewelry-television-jtv-love-your-heart-aha-go-red-for-women
Mimi’s Cafe is raising awareness throughout February, American Heart Month, by supporting the American Heart Association’s® Go Red For Women® movement and its mission to turn America red. Mimi’s was the first restaurant to support Go Red For Women on a national scale. In its second year, Mimi’s will shout louder and stand stronger in the fight against heart disease, the number one killer of women, with its Mimi’s Goes Red campaign.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60186-mimi-s-cafe-go-red-for-women-put-your-hearts-up
The public is generally satisfied with cancer research progress over the past 20 years. However, they believe it takes too long for new cancer medicines to reach patients and that their countries invest too little in fighting cancer. Most fear that the current economic crisis will slow cancer research progress. This is according to the PACE Cancer Perception Index: A Six-Nation, Public Opinion Survey of Cancer Knowledge and Attitudes, released today in advance of World Cancer Day, which is recognized on February 4, 2013.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60140-lilly-oncology-pace-cancer-perception-index
In his fifth annual letter, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, highlights how setting clear goals and accurate measurement are key to improving the lives of poor people around the globe.
The letter describes remarkable progress from schools in the United States to health care in Ethiopia and makes the case that continued investments in these efforts have made a measurable difference for millions of the world’s poorest people. A core reason was the world’s commitment to setting clear goals and identifying the right measures to drive progress towards those goals.
To view Multimedia News Release, go to http://www.multivu.com/mnr/49396-bill-melinda-gates-foundation-fifth-annual-letter
Jerome Bettis and Robin Miller are teaming up with Sanofi US to raise awareness of life-threatening allergic reactions (anaphylaxis) and spread the word that Auvi-Q™ (epinephrine injection, USP) is now available by prescription in pharmacies nationwide. Bettis, who is allergic to shellfish, and Miller, who is allergic to eggs, hope to help educate adults and caregivers of children at risk for severe allergic reactions.
Auvi-Q is the first-and-only epinephrine auto-injector with audio and visual cues for the emergency treatment of life-threatening allergic reactions in people who are at risk for or have a history of anaphylaxis. The size and shape of a credit card and the thickness of a smart phone, Auvi-Q is a breakthrough in epinephrine auto-injector design that talks patients and caregivers step-by-step through the injection process.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59439-auvi-q-epinephrine-injection-usp-now-available-by-prescription-in-u-s
The AMWAY ONE BY ONE® Campaign for Children is marking its 10th anniversary with a remarkable accomplishment – helping 10 million children live better lives.
Amway has been committed to providing people around the globe with hope and opportunity for more than five decades. In 2003, Amway chose to focus its charitable efforts on the single global social cause of helping children live better lives by harnessing the power of interpersonal and business relationships made possible by Amway distributors and employees.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55864-amway-one-by-one-campaign-for-children-10th-anniversary
Every 40 seconds a stroke occurs in the United States, according to the American Heart Association/American Stroke Association. To raise awareness about F.A.S.T. — an acronym to recognize and respond to the sudden warning signs of stroke, the American Heart Association/American Stroke Association and Ad Council are unveiling a new, national multimedia public service advertisement (PSA) campaign. F.A.S.T. is designed to help bystanders spot a stroke fast because the quicker a stroke victim receives medical attention, the greater his or her chances of survival and a better recovery. To view Multimedia News Release, go to http://www.multivu.com/mnr/58828-ad-council-american-stroke-association-stroke-awareness-f-a-s-t
Novo Nordisk, a world leader in diabetes care, today kicked off the first NovoLog® Community Star contest. As part of the program, type 2 diabetes patients successfully managing their blood sugar with NovoLog® (insulin aspart [rDNA origin] injection) are invited to visit www.novolog.com and tell us how they’re giving back to their local communities.
Now through March 15, NovoLog® patients can submit their story and photo online for the chance to be crowned a NovoLog® Community Star. Finalists will be selected by a panel of judges, and each will receive a $5,000 donation to a local diabetes-related organization of their choice. One grand prize winner will also receive a one-year online subscription to Weight Watchers® to help with their diabetes management.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59947-novo-nordisk-first-novolog-community-star-contest-type-2-diabetes-patients
SIRO Clinpharm, a leading full service clinical research organization, unveiled its new brand identity on Friday. The new look affirms the recent transformation in the company’s business strategy.
“With the vast experience garnered over the past 16 years, SIRO was set to take a leap forward. With its customer centric leadership, we have built depth in various areas of competencies, leveraging our 4 pillars – people, processes, technologies and solutions,” said Dr. Gautam Daftary, founder and chairman, SIRO Clinpharm.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58672-SIRO-Clinpharm-unveils-new-brand-identity
One widely used definition, developed by the World Health Organization and the Food and Agriculture Organization of the United Nations, is that probiotics are “live microorganisms, which, when administered in adequate amounts, confer a health benefit on the host.” Visit for More Details: http://aoprobio.com/products-list/
A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic issues associated with Hepatitis C (HCV).
While the total number of infected individuals is unknown due to a lack of available data, the World Health Organization (WHO) estimates that approximately 150 million people globally are currently living with the blood-borne infectious disease, HCV. Of these, up to two thirds will develop chronic liver disease and one in five will develop cirrhosis. HCV is also the leading cause of liver transplantation worldwide and in the US the disease now accounts for more deaths than HIV.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58671-janssen-silent-pandemic-hepatitis-c
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, Epilog.us [http://www.Epilog.us], now features a panel discussion of leading experts on the role of rational polytherapy in the treatment of patients with epilepsy, led by Dr. Barry Gidal, Professor of Pharmacy and Neurology/Division Chair, University of Wisconsin. Dr. Gidal also brings forward discussion on the mechanism of action of specific antiepileptic drugs (AEDs). Additional topics include: AED pharmacokinetics; patient adherence and AEDs; and drug interactions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59891-upsher-smith-epilog-us-pharmacodynamics-of-antiepileptic-drugs-aeds
